Previously, we showed that a conversion of hypermethylated to wild‐type (unmethylated) BRCA1 promoter frequently takes place in high‐grade serous ovarian cancer upon recurrence [10]. This evidence concerns the gene BRCA1 and ovarian serous adenocarcinoma.